Colon Cancer Genetics Group
This Western General Hospital group is focussed on reducing the incidence and death rate from cancer of the large bowel.
The Colon Cancer Genetics Group is part of the new Institute of Genetics and Molecular Medicine at the Western General Hospital.
The Head of this group is Professor Malcolm Dunlop.
We are using genetic approaches to reduce the incidence and death rate from cancer of the large bowel, and investigating how aspirin prevents cancer.
We are working to identify colorectal susceptibility genes, and studying specific aspects of chemoprevention.
Collaborations and Results
We have already identified new genes and developed novel insights about the cause of bowel cancer.